A detailed history of Abound Wealth Management transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Abound Wealth Management holds 44 shares of TAK stock, worth $606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 44 -0.0%
Holding current value
$606
Previous $570,000 9.82%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 08, 2024

SELL
$13.36 - $15.43 $1,015 - $1,172
-76 Reduced 63.33%
44 $628,000
Q2 2023

Aug 08, 2024

BUY
$15.57 - $17.11 $622 - $684
40 Added 50.0%
120 $1.88 Million
Q1 2023

Aug 07, 2024

BUY
$15.28 - $16.48 $1,222 - $1,318
80 New
80 $1.31 Million
Q4 2022

Aug 07, 2024

BUY
$12.42 - $15.62 $24 - $31
2 Added 2.56%
80 $1.24 Million
Q3 2022

Aug 07, 2024

SELL
$12.8 - $28.65 $25 - $57
-2 Reduced 2.5%
78 $1.02 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.8B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.